🌱 KidneyEnergy.com

← brief for 2026-11-15 · Slowing decline

Substantial declines in eGFR after initiation of SGLT2-inhibitors associate with increased short-term mortality in hospitalized patients with CKD.

Article C Peer reviewed Observational

Key takeaways

This study found that a sharp drop in kidney function after starting a common diabetes drug is linked to higher short-term death risk. It was an observational study of hospitalized patients, so it shows a link, not proof of cause. Doctors should watch for this drop closely.

Who did this work

Gao Q · Ma Z · Ren W · Yu Y · Wu L · Zhang Z · Wu Z · Zhou S · Su L · Li Y · Luo F · Lin Y

Source

Article · PubMed, the drug frontier · 2026 Oct 29
https://pubmed.ncbi.nlm.nih.gov/43034494/